2m 2m 2m 2m 2m 2m 2m
Macrogenics (MGNX)
NASDAQ
$3.74+$0.05 (+1.36%)
Price as of Aug 03, 2026 10:22 AM EDT- $234.5MMarket Cap
- 133.54%1-Year Change
- BiotechnologyIndustry
Macrogenics (MGNX)
$3.74+$0.05 (+1.36%)
MGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.69 | ||
Change | -$0.09 (-2.38%) | ||
Open | $3.79 | ||
High | $3.79 | ||
Low | $3.61 | ||
Previous Close | $3.78 | ||
Volume | 410,834 | ||
30-Day Average Volume | 820,617 | ||
1-Week Change | -0.27% | ||
1-Month Change | -20.13% | ||
1-Year Change | 133.54% | ||
3-Year Change | -22.64% | ||
5-Year Change | -85.22% | ||
Fundamentals | |||
Shares Outstanding | 63.6M | ||
Total Assets | $217.9M | ||
Market Cap | $234.5M | ||
Enterprise Value | $168.0M | ||
Period: QTR TTM FY | |||
Revenue | $570,000.00 | ||
Net Income | -$36.8M | ||
Free Cash Flow | -$36.2M | ||
EBIT | -$31.9M | ||
EBITDA | -$30.2M | ||
Net Working Capital | $86.6M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 295 | ||
P/B | 11 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue